Use of a truncated elF-5A1 polynucleotide to induce apoptosis in cancer cells

Details for Australian Patent Application No. 2009288092 (hide)

Owner Senesco Technologies, Inc.

Inventors Thompson, John E.; Sun, Zhong; Taylor, Catherine; Dondero, Richard; Chen, Zhenyu

Agent Shelston IP

Pub. Number AU-A-2009288092

PCT Pub. Number WO2010/028093

Priority 12/400,742 09.03.09 US; 61/093,749 03.09.08 US

Filing date 2 September 2009

Wipo publication date 11 March 2010

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61K 31/7105 (2006.01) - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links

A61K 39/235 (2006.01) Medicinal preparations containing antigens or antibodies - Adenoviridae

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

31 March 2011 PCT application entered the National Phase

  PCT publication WO2010/028093 Priority application(s): WO2010/028093

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009288095-Peptides presenting an epitope of an a domain of factor H binding protein

2009288088-Agents and methods for treatment of pain